Patients

Physicians

Labs

Products Outside US

TriPath

Cervical Cytology

Molecular Oncology BD Affirm™ VPIII
Microbial
Identification Test BD ProEx™ C
Reagent Programs in Development

Non-Gyn

Product Inserts

MSDS Documents

Resources

Labs Main Page

TriPath Home


	BD revolutionized the field of cellular analysis with the BD FACS™ fluorescence-activated cell sorter, introduced in 1973. Learn more about BD's history »

Molecular Oncology
BD ProEx™ C Reagent

Reimbursement

BD Diagnostics - TriPath , the makers of the BD ProEx™ C reagent, offers its customers extensive payer relations support from securing coverage and reimbursement from their insurance payers to training on the appropriate CPT coding.

If you have general questions regarding payer coverage and reimbursement, appropriate CPT code usage or need help completing your claim form when reporting the use of BD ProEx™ C reagent, contact your local BD Diagnostics - TriPath representative.

CPT Code for Reporting Immunocytochemical or Immunohistochemical (ICC, IHC) testing

Procedural reporting of an Immunocytochemistry test is accomplished by the use of a general application CPT code intended for both Immunohistochemical and Immunocytochemical applications.

CPT 88342 – Immunohistochemistry / Immunocytochemistry (including tissue immunoperoxidase), each antibody. For morphometric analysis of IHC or ICC.

Site Map Terms & Conditions \| Permission Request \| Trademarks BD Worldwide
BD 1 Becton Drive Franklin Lakes, NJ USA 07417 201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2010 BD